Clinical experience with diamorphine in advanced malignant disease.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004361:Drug Tolerance; D005260:Female; D003932:Heroin / Q000627:therapeutic use*; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D008875:Middle Aged; D009019:Morphinans / Q000008:administration & dosage / Q000009:adverse effects; D009369:Neoplasms / Q000188:drug therapy*; D010146:Pain / Q000188:drug therapy; D019966:Substance-Related Disorders; D013727:Terminal Care; D013997:Time Factors
D009019:Morphinans; D003932:Heroin